Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.67 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | TACR2 | P21452 | 1/20 | 0.45 |
| ▸ | TACR1 | P25103 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11291447 | 0.88 | SIGMAR1 (0.66) | SIGMAR1OPRM1KCNH2HTR2A | |
| Hydrochloric Acid SCHEMBL11284430 | 0.87 | SIGMAR1 (0.64) | SIGMAR1OPRM1KCNH2HTR2A | |
| SCHEMBL11282845 | 0.86 | SIGMAR1 (0.67) | SIGMAR1OPRM1KCNH2HTR2ADRD3 | |
| SCHEMBL11289963 | 0.85 | HTR2A (0.51) | SIGMAR1OPRM1KCNH2HTR2ADRD3 | |
| Hydrochloric Acid SCHEMBL11281215 | 0.84 | HTR2A (0.50) | SIGMAR1OPRM1KCNH2HTR2ADRD3 | |
| SCHEMBL11282865 | 0.82 | OPRM1 (0.51) | SIGMAR1OPRM1KCNH2HTR2ADRD3 | |
| SCHEMBL11365324 | 0.82 | TACR2 (0.58) | HTR2ATACR2TACR1 | |
| SCHEMBL17317196 | 0.81 | SIGMAR1 (0.73) | SIGMAR1OPRM1KCNH2 | |
| SCHEMBL17317200 | 0.81 | SIGMAR1 (0.73) | SIGMAR1OPRM1KCNH2 | |
| SCHEMBL11284561 | 0.80 | SIGMAR1 (1.00) | SIGMAR1OPRM1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0061333-A1 | 9-(2-(3-Indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones | SYNTEX (U.S.A.) INC. (US) | 1982-09-29 | — | — | EP | claimed |
| US-4332804-A | TREATMENT OF HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIA, MIGRAINE, VASOSPASTIC DISORDERS AND ASTHMA | SYNTEX (U.S.A.) INC. (US) | 1982-06-01 | — | — | US | claimed |
| EP-0061333-A1 | 9-(2-(3-Indolyl)ethyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones | SYNTEX (U.S.A.) INC. (US) | 1982-09-29 | — | — | EP | disclosed |
| US-4332804-A | TREATMENT OF HYPERTENSION, CONGESTIVE HEART FAILURE, ARRHYTHMIA, MIGRAINE, VASOSPASTIC DISORDERS AND ASTHMA | SYNTEX (U.S.A.) INC. (US) | 1982-06-01 | — | — | US | disclosed |